88 related articles for article (PubMed ID: 7594708)
1. N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients.
Roberts RL; Aroda VR; Ank BJ
J Infect Dis; 1995 Dec; 172(6):1492-502. PubMed ID: 7594708
[TBL] [Abstract][Full Text] [Related]
2. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection.
Szelc CM; Mitcheltree C; Roberts RL; Stiehm ER
J Infect Dis; 1992 Sep; 166(3):486-93. PubMed ID: 1500735
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
Jenkins M; Mills J; Kohl S
Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms.
Dallegri F; Patrone F; Frumento G; Sacchetti C
J Natl Cancer Inst; 1984 Aug; 73(2):331-9. PubMed ID: 6205210
[TBL] [Abstract][Full Text] [Related]
5. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine.
de Quay B; Malinverni R; Lauterburg BH
AIDS; 1992 Aug; 6(8):815-9. PubMed ID: 1418777
[TBL] [Abstract][Full Text] [Related]
6. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
[TBL] [Abstract][Full Text] [Related]
7. Characterization of natural killer and antibody-dependent cellular cytotoxicity of preterm infants against human immunodeficiency virus-infected cells.
Merrill JD; Sigaroudinia M; Kohl S
Pediatr Res; 1996 Sep; 40(3):498-503. PubMed ID: 8865290
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes.
Katz P; Simone CB; Henkart PA; Fauci AS
J Clin Invest; 1980 Jan; 65(1):55-63. PubMed ID: 6243141
[TBL] [Abstract][Full Text] [Related]
9. Complement activation by HIV-1-infected target cells enhances IL-2-stimulated but not unstimulated ADCC activity mediated by peripheral blood mononuclear cells.
Sereti I; Spear GT
Clin Immunol Immunopathol; 1996 Jan; 78(1):77-82. PubMed ID: 8599888
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro.
Gillissen A; Bartling A; Schoen S; Schultze-Werninghaus G
Lung; 1997; 175(4):235-42. PubMed ID: 9195551
[TBL] [Abstract][Full Text] [Related]
11. The role of oxidative imbalance in progression to AIDS: effect of the thiol supplier N-acetylcysteine.
Malorni W; Rivabene R; Lucia BM; Ferrara R; Mazzone AM; Cauda R; Paganelli R
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1589-96. PubMed ID: 9840292
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine enhances receptor-mediated phagocytosis by human neutrophils.
Ohman L; Dahlgren C; Follin P; Lew D; Stendahl O
Agents Actions; 1992 Jul; 36(3-4):271-7. PubMed ID: 1326880
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.
Ojo-Amaize EA; Nishanian P; Keith DE; Houghton RL; Heitjan DF; Fahey JL; Giorgi JV
J Immunol; 1987 Oct; 139(7):2458-63. PubMed ID: 2821115
[TBL] [Abstract][Full Text] [Related]
14. N-acetyl cysteine reduces oxidative toxicity, apoptosis, and calcium entry through TRPV1 channels in the neutrophils of patients with polycystic ovary syndrome.
Köse SA; Nazıroğlu M
Free Radic Res; 2015 Mar; 49(3):338-46. PubMed ID: 25666878
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus-infected cells.
Kohl S; Sigaroudinia M; Charlebois ED; Jacobson MA
J Infect Dis; 1996 Nov; 174(5):1105-8. PubMed ID: 8896517
[TBL] [Abstract][Full Text] [Related]
16. Primary cytotoxicity against the envelope glycoprotein of human immunodeficiency virus-1: evidence for antibody-dependent cellular cytotoxicity in vivo.
Tanneau F; McChesney M; Lopez O; Sansonetti P; Montagnier L; Rivière Y
J Infect Dis; 1990 Oct; 162(4):837-43. PubMed ID: 1698205
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients.
Pathak S; Stern C; Vambutas A
Immunol Res; 2015 Dec; 63(1-3):236-45. PubMed ID: 26392121
[TBL] [Abstract][Full Text] [Related]
18. Possible availability of N-acetylcysteine as an adjunct to cytokine therapy for hepatocellular carcinoma.
Tsuyuki S; Yamauchi A; Nakamura H; Kinoshita K; Gomi T; Tanaka K; Inamoto T; Yamaoka Y
Clin Immunol Immunopathol; 1998 Aug; 88(2):192-8. PubMed ID: 9714697
[TBL] [Abstract][Full Text] [Related]
19. Glutathione and N-acetylcysteine suppression of human immunodeficiency virus replication in human monocyte/macrophages in vitro.
Ho WZ; Douglas SD
AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1249-53. PubMed ID: 1520537
[TBL] [Abstract][Full Text] [Related]
20. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication.
Raju PA; Herzenberg LA; Herzenberg LA; Roederer M
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):961-7. PubMed ID: 7811547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
